GLP3-RT 10mg is a high-purity synthetic peptide corresponding to retatrutide (research designation LY3437943), supplied by Echo Peptides exclusively for laboratory and in-vitro research use. It is a single-molecule triple agonist engineered to engage three metabolic receptors at once — the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor.

As a research reference compound, GLP3-RT is valued for the way its unified structure lets investigators probe converging incretin and glucagon signaling within a single molecular framework rather than combining separate agonists. Its fatty-acid conjugate and targeted structural modifications are designed to improve stability in cell-culture and preclinical model systems, making it a useful tool for researchers studying multi-receptor metabolic pathways.

Key research areas

  • Multi-receptor metabolic and energy-expenditure models
  • Glucose homeostasis and appetite-regulation signaling pathways
  • Lipid metabolism and body-weight-related research paradigms
  • Combined incretin and glucagon receptor signaling in preclinical and in-vitro systems

Specifications

  • Amount: 10mg
  • Form: Lyophilized white powder
  • Modifications: Triple agonist with fatty-acid conjugate
  • Solubility: Soluble in bacteriostatic water for research use
  • Storage: Refrigerate at 2–8°C; long-term stability when lyophilized

Each batch is third-party tested for identity and purity, and a Certificate of Analysis is available. GLP3-RT 10mg is provided strictly for in-vitro laboratory research use only — not for human or veterinary use, and not for diagnostic or therapeutic purposes.